Since filoviruses were first recognized in 1967, more than 1,800 cases of human infection have been reported, with mortality rates as high as 90%. Interest in filoviruses has increased with the globalization of travel and trade, and the attendant potential for their appearance in new contexts, and the concern that highly pathogenic viruses may be exploited as biological weapons. Current treatment options for infected individuals are only supportive; nonetheless, early accurate diagnosis is critical for the control of contagion and is likely to become an important factor in clinical outcome as new management strategies come into practice. PCR-based assays have become fundamental tools in clinical diagnosis and outbreak control (6, 10, 13) . A major challenge to the utility of these assays is the diversity of filoviral genomes. To address this challenge we developed a consensus PCR (cPCR) method that utilizes a cocktail of specific primers in a one-step reverse transcription-PCR (RT-PCR). The resulting assay is less sensitive to sequence drift than assays currently in use. This method has been joined to a program for sequence analysis of cPCR product that allows automated speciation.
The primers were designed by using Greene SCPrimer software (http://scprimer.cpmc.columbia.edu/SCPrimerApp.cgi). The program uses a greedy algorithm to identify the most conserved sequences and create the minimum set of primers needed for amplification of all sequences in the alignment. Primers are selected within standard design constraints (T m ϭ 55 to 65°C, GC content ϭ 40 to 60%, no hairpins); degenerate positions are introduced in cases where necessary ( Table 1) .
The assay was standardized using synthetic DNA standards containing Zaire ebolavirus (ZEBOV), Sudan ebolavirus (SEBOV), and Lake Victoria marburgvirus (MARV) L-gene sequences cloned into pGEM-T-Easy vector system (Promega, Fermantas, Lithuania). The PCR parameters (MgCl 2 concentration, annealing temperature, primer concentration, and enzymatic system) were optimized individually. We found 2.5 mM MgCl 2 , 58°C, 0.5 M concentrations of each primer, and the QIAGEN One-Step RT-PCR kit (QIAGEN, Valencia, CA) to be optimal.
Synthetic RNA standards were generated from linearized target sequence plasmids using T7 polymerase (mMessage mMachine; Invitrogen, Carlsbad, CA). After quantitation by UV spectrometry, RNA was serially diluted in 2.5 g of yeast tRNA (Sigma)/ml and analyzed by filovirus consensus one-step RT-PCR (RT: 50°C for 30 min; PCR: 94°C for 12 min to inactivate the polymerase antibodies, followed by 94°C for 30 s, 58°C for 50 s, and 72°C for 90 s for 35 cycles, with a final extension for 7 min). The sensitivity of the assay was 50 to 500 RNA copies per assay, where each assay represents 100 l of blood.
Nineteen filovirus strains were tested, including MARV strains Musoke, Popp, Voege, Angola, Ozolin, 05DRC99, 07DRC99, 09DRC99, and RAVN; Reston ebolavirus (REBOV) strain Pennsylvania; Cote d'Ivoire ebolavirus (CIEBOV); SEBOV strains Gulu, Boniface, Maleo, and Yambio; and ZEBOV strains Mayinga, Zaire95, Gabon 1994, and Gabon 1996. All extracts yielded products of appropriate length. No amplification products were detected in extracts of uninfected cells or cells infected with Lassa fever, Crimean-Congo hemorrhagic fever, or Rift Valley fever viruses.
Performance with clinical materials was evaluated using blood from 13 human victims of filoviral hemorrhagic fevers, including five cases of ZEBOV from the 1995 Kikwit outbreak in the Democratic Republic of the Congo (DRC), four cases of MARV VHF from the 2000 Durba outbreak in the DRC, and four cases of MARV VHF from the 2005 Uige outbreak in Angola. Infections had been previously diagnosed through virus isolation or RT-PCR. All samples yielded positive results. RNA was extracted from 200 l of blood. After dissolution in 10 l of water, 5 l of total RNA were reverse transcribed using random hexamer primers. The resulting cDNA was dried to facilitate shipment to Columbia University. Prior to PCR amplification, the cDNA was reconstituted in 5 l of water.
Templates for dideoxy sequencing were obtained by excising the band of interest after size fractionation of PCR products by 1% agarose gel electrophoresis. A set of 40 filovirus L-gene sequences (593 nucleotides [nt]) comprising 18 newly sequenced strains and 22 previously available in GenBank (July 2006) were aligned by using the program CLUSTAL X (version 1.83) (11) . Phylogenetic analysis was performed by using the best model of nucleotide substitution (according to Modeltest [8] , HKY 85 [3] , with gamma distribution correction ϭ 0.304). Programs from the MEGA package (version 3) (4) were used to produce phylogenetic trees, reconstructed through the neighborjoining method. The statistical significance of a particular tree topology was evaluated by bootstrap resampling of the sequences 1,000 times. The phylogenetic tree obtained is shown A pairwise sequence comparison was done within filovirus sequences to assess the potential for establishing a simple program for classification of filoviral species and lineages similar to programs previously built for mumps (7), dengue serotype 1 (2), and adenoviruses (1). Pairwise comparisons were done by global alignment using the Needleman Wunsch algorithm (5), implemented by a program from EMBOSS (the European molecular biology open software suite) (9) . This analysis allowed the determination of species and lineage in all clinical samples (Fig. 2) . The validity of the method was confirmed by analysis of variance, comparing the scores of sequence comparisons within species or lineages to comparisons between genotypes. The automated program for filoviral analysis is available for public use at http://www.greeneidlab .columbia.edu. Sequence submissions are retained in the database; each use results in incorporation of filoviral sequences introduced since it was last queried.
The cPCR assay described here is not the first reported for filovirus surveillance. Sanchez et al. established an assay in 1999 that continues to serve successfully in laboratory and field applications (10) . However, the second-generation cPCR assay we describe here has the advantage of yielding a 640-nt product (including primer sequence) that can be sequenced for automated phylogenetic analysis, allowing a more accurate placement of newly identified filovirus-positive samples relative to existing species, lineages, and strains. The performance of the assay has been validated with all known filovirus strains, including CIEBOV, a species for which there is as yet no published L-gene sequence. The database that is the foundation for automated phylogenetic analysis is continually updated ensuring currency of sequence information. Use of this technology is anticipated to provide insight into the appearance and distribution of known and novel filoviral species and lineages and to enhance rapid response to these and other emerging pathogens. 
